Great West Life Assurance CO Arcutis Biotherapeutics, Inc. Transaction History
Great West Life Assurance CO
- $69.9 Billion
- Q3 2025
A detailed history of Great West Life Assurance CO transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 25,829 shares of ARQT stock, worth $645,725. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,829
Previous 25,829
-0.0%
Holding current value
$645,725
Previous $363,000
32.51%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ARQT
# of Institutions
264Shares Held
122MCall Options Held
404KPut Options Held
133K-
Rubric Capital Management LP New York, NY10.7MShares$269 Million3.33% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.5MShares$262 Million5.93% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA9.87MShares$247 Million7.87% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$216 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.25MShares$181 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $1.5B
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...